This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
World Acceptance (WRLD) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
WRLDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Blueprint Medicines (BPMC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Upstart Gears Up to Report Q4 Earnings: Buy, Sell or Hold the Stock?
by Anirudha Bhagat
Recent rate cuts by the Federal Reserve, innovative product launches and an AI-driven consumer lending model are likely to have boosted UPST's Q4 revenues.
XLFPositive Net Change LCNegative Net Change UPSTNegative Net Change SOFIPositive Net Change
artificial-intelligence earnings-estimates-revisions earnings-preview earnings-report earnings-surprise fin-tech
Should You Buy Pacira (PCRX) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PCRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
JKHY Q2 Earnings Beat: Will 2025 Outlook Drag the Stock Down?
by Zacks Equity Research
Jack Henry & Associates' second-quarter fiscal 2025 results reflect modest growth across its Core, Payments, Complementary and Corporate & Other segments.
CLSNegative Net Change JKHYNegative Net Change CRWDPositive Net Change BILLNegative Net Change
fin-tech finance tech-stocks
3 Stocks Thriving Despite Tariffs Concerns
by Ethan Feller
While ongoing tariff news shakes the market Meta Platforms, Amazon and Interactive Brokers shares continue to rally
AMZNNegative Net Change IBKRPositive Net Change METANegative Net Change
artificial-intelligence fin-tech tech-stocks
Bull of the Day: Sea Limited (SE)
by Ethan Feller
Sea Limited stock continues to gain momentum as earnings forecasts rise
SENegative Net Change
e-commerce fin-tech gaming tech-stocks
Bull of the Day: Virtu Financial (VIRT)
by David Bartosiak
All-time highs for this HFT firm have come with increased earnings as well.
VIRTNegative Net Change
fin-tech
Upstart Holdings Stock Soars 36% in 3 Months: Time to Hold or Fold?
by Anirudha Bhagat
UPST's 36% surge highlights strong AI-driven growth, but its high valuation suggests holding the stock is the best move for now.
XLFPositive Net Change LCNegative Net Change UPSTNegative Net Change SOFIPositive Net Change
artificial-intelligence computers fin-tech tech-stocks
SoFi Technologies Stock Gains 121% in 6 Months: Buy, Hold, or Sell?
by Shuvra Shankar Dey
Given the continuous surge in SOFI shares, we evaluate the stock's current position to determine how to play it now.
BACPositive Net Change WFCNegative Net Change JPMPositive Net Change SOFIPositive Net Change
fin-tech finance
Visa & Elon Musk's X: A Power Play in the Race for Fintech Dominance?
by Kaibalya Pravo Dey
As X Money integrates with Visa Direct, millions of X users could start using Visa's network, driving up transaction volume and fees.
MANegative Net Change VNegative Net Change TSLAPositive Net Change PYPLNegative Net Change
business-services creator-economy fin-tech finance payments social-media
Grupo Aeroportuario del Centro Norte (OMAB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
OMABNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UiPath (PATH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PATHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ease-of-Use AI Platform DeepSeek Send U.S. Pre-Markets Reeling
by Mark Vickery
We're looking at a big drop in pre-market equities to start the last week on the first month of 2025.
NVDANegative Net Change SOFIPositive Net Change
artificial-intelligence earnings fin-tech
Vor Biopharma Inc. (VOR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VORNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Adidas AG (ADDYY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADDYYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
2 Cheap Growth Stocks to Buy Now for Under $20
by Benjamin Rains
Today we dig into two cheap stocks trading for under $20--WisdomTree and SoFi--that investors might want to buy for long-term upside.
SOFIPositive Net Change WTPositive Net Change
fin-tech finance tech-stocks
4 Top-Ranked Stocks With Solid Net Profit Margins to Buy Now
by Anirudha Bhagat
Buy these four top-ranked stocks, CSTL, OPFI, GCT and QIFU, with solid net profit margins to enhance your portfolio returns.
QFINNegative Net Change CSTLNegative Net Change OPFIPositive Net Change GCTPositive Net Change
computers fin-tech finance medical medical-devices tech-stocks
WDAY Appears a Solid Portfolio Pick on Healthy Subscription Revenues
by Zacks Equity Research
With healthy fundamentals and upward estimate revisions, Workday appears to be an enticing investment option at the moment.
QCOMPositive Net Change IDCCPositive Net Change WDAYNegative Net Change ANETNegative Net Change
artificial-intelligence fin-tech tech-stocks
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio
by Zacks Equity Research
Visa, AbbVie, Analog Devices and Precipio are included in this Analyst Blog.
ADIPositive Net Change VNegative Net Change ABBVNegative Net Change PRPONo Net Change
fin-tech
After Golden Cross, Coterra Energy (CTRA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CTRANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, USA Compression Partners (USAC)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
USACNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Plains All American Pipeline (PAA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PAANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Arc Resources (AETUF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AETUFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bull of the Day: nCino (NCNO)
by David Bartosiak
The market is experiencing some volatility here, could that present an opportunity to buy the dip in nCino?
NCNOPositive Net Change
fin-tech